© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
June 04, 2021 12:36pm
Pay special attention to prevent permanent hair loss.
June 03, 2021 05:04pm
June 03, 2021 01:00pm
June 02, 2021 06:28pm
June 02, 2021 01:55pm
June 02, 2021
The FDA approved Cosentyx (secukinumab) to treat moderate-to-severe plaque psoriasis in children aged 6 years and older.
AmerisourceBergen Corporation today announced the completion of its acquisition of the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses.
June 01, 2021
The FDA has approved sotorasib (Lumakras; Amgen Inc) for the treatment of non-small cell lung cancer in patients with KRAS G12C genetic mutations and who have received at least 1 prior therapy.
Moderna has initiated the rolling submission process for the biologics license application for its COVID-19 vaccine mRNA-1273.
A recent study examined whether individuals with migraine are at increased risk of abdominal aortic aneurysm.
May 31, 2021
Migraine sufferers reported worsened symptoms during social distancing, which may be attributed to reduced sleep quality and physical activity.
Here’s a preview of the featured content to watch for this week on Drug Topics®.
May 28, 2021
The COVID-19 pandemic has exacerbated the "hidden epidemic” of drug diversion. The good news is that health care systems are recognizing the need to switch to a more proactive approach.
Here’s a roundup of the latest coronavirus-related news.
May 27, 2021
Sotrovimab is authorized to treat COVID-19 patients 12 years of age and older with mild-to-moderate infection and who are at high risk for severe disease progression.